Peyronie's Disease
Peyronie's disease is a connective tissue disorder involving the development of fibrous scar tissue (plaque) inside the penis. This plaque causes curved, painful erections and can lead to erectile dysfunction. The condition has two phases: acute (active inflammation, 6-18 months) and chronic (stable plaque, curvature established).
Prevalence
Affects an estimated 6-10% of men, though many cases go unreported. Most common in men aged 40-70. Some studies suggest prevalence may be higher due to underreporting.
Who It Affects
Most common in middle-aged and older men. Risk factors include genetics, penile injury, connective tissue disorders (Dupuytren's contracture), diabetes, and certain medications.
Important: This information is for educational purposes only and does not constitute medical advice. Regenerative therapies are investigational and not FDA-approved to treat this condition.
Common Symptoms
Common Causes & Risk Factors
Traditional Treatment Options
Oral Medications
Vitamin E, pentoxifylline, or colchicine to reduce plaque progression.
Limitations: Limited evidence of effectiveness. May help in acute phase but rarely resolves established plaque.
Xiaflex (Collagenase) Injections
FDA-approved injection that breaks down collagen in the plaque.
Limitations: Requires multiple injection cycles. Only for curvature >30 degrees with palpable plaque. Risk of penile fracture.
Penile Traction Therapy
Device worn to stretch the penis and potentially reduce curvature.
Limitations: Requires 30+ minutes daily for months. Results modest and variable.
Surgical Correction
Procedures including plication, grafting, or penile implant for severe cases.
Limitations: Reserved for stable disease. May cause shortening, numbness, or ED. Implant is irreversible.
Regenerative Medicine Approach
How Regenerative Therapy May Help
Regenerative medicine for Peyronie's disease explores whether biologics may help modulate the fibrotic process and support tissue health. The approach aims to deliver anti-inflammatory and anti-fibrotic signals to the affected tissue, particularly during the acute phase.
Potential Benefits Being Studied:
- Contains growth factors that may influence tissue remodeling
- Being studied for potential anti-fibrotic effects
- May help modulate inflammation during acute phase
- Minimally invasive injection procedure
- May be explored as alternative or complement to other treatments
- An area of ongoing research
Biologics Used:
Exosomes with anti-inflammatory properties
Stem cell preparations being studied for fibrotic conditions
Frequently Asked Questions
Can this eliminate the plaque?
There is no proven treatment that reliably eliminates Peyronie's plaque. Regenerative therapies are being studied for their potential effects on fibrosis, but results vary and these treatments are investigational.
Is this better in the acute or chronic phase?
Research suggests that anti-inflammatory approaches may be more relevant during the acute (inflammatory) phase. Once plaque is calcified and stable, treatment options become more limited. Early evaluation is important.
How is treatment administered?
Biologics are typically injected directly into or near the plaque under local anesthesia. Protocols vary depending on disease stage and provider recommendations.
Ready to Explore Your Options?
Schedule a free consultation to discuss peyronie's disease and learn if regenerative medicine may be right for you.
Important Disclaimer
Regenerative therapies for Peyronie's disease are investigational and not FDA-approved for this condition. Results vary. Consult with a urologist specializing in Peyronie's disease for comprehensive evaluation and treatment options.